These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 9316655

  • 21. Serum levels of PSA, ALP, ICTP, and BSP in prostate cancer patients and the significance of ROC curve in the diagnosis of prostate cancer bone metastases.
    Wei RJ, Li TY, Yang XC, Jia N, Yang XL, Song HB.
    Genet Mol Res; 2016 Jun 03; 15(2):. PubMed ID: 27323113
    [Abstract] [Full Text] [Related]

  • 22. Contribution of bone scintigraphy, prostatic acid phosphatase and prostate-specific antigen to the monitoring of prostatic cancer.
    Hetherington JW, Siddall JK, Cooper EH.
    Eur Urol; 1988 Jun 03; 14(1):1-5. PubMed ID: 2449352
    [Abstract] [Full Text] [Related]

  • 23. Diagnostic Role of Serum Free-to-Total Prostate Specific Antigen (PSA) Ratio in Prostate Cancer with Serum Total Concentration of PSA below 4 ng/mL.
    Chang CC, Lee YC, Tsai HW, Yii SC, Yen TH, Chu FY.
    Asian Pac J Cancer Prev; 2015 Jun 03; 16(13):5261-4. PubMed ID: 26225663
    [Abstract] [Full Text] [Related]

  • 24. Changes in prostate-specific antigen, markers of bone metabolism and bone scans after treatment with radium-223.
    Nome R, Hernes E, Bogsrud TV, Bjøro T, Fosså SD.
    Scand J Urol; 2015 Jun 03; 49(3):211-7. PubMed ID: 25515952
    [Abstract] [Full Text] [Related]

  • 25. Relationship between prostate-specific antigen, clinical stage, and degree of bone metastasis in patients with prostate cancer: comparison with prostatic acid phosphatase and alkaline phosphatase.
    Akimoto S, Furuya Y, Akakura K, Shimazaki J, Ito H.
    Int J Urol; 1997 Nov 03; 4(6):572-5. PubMed ID: 9477186
    [Abstract] [Full Text] [Related]

  • 26. Systematic association of PAP and PSA determinations to bone scintigraphy in prostatic cancer.
    Fincker F, Sauvan R, Pasquier J.
    Am J Clin Oncol; 1988 Nov 03; 11 Suppl 2():S68-70. PubMed ID: 2468277
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. The CT flare response of metastatic bone disease in prostate cancer.
    Messiou C, Cook G, Reid AH, Attard G, Dearnaley D, de Bono JS, de Souza NM.
    Acta Radiol; 2011 Jun 01; 52(5):557-61. PubMed ID: 21498309
    [Abstract] [Full Text] [Related]

  • 31. Prospective Comparison of 18F-Fluoromethylcholine Versus 68Ga-PSMA PET/CT in Prostate Cancer Patients Who Have Rising PSA After Curative Treatment and Are Being Considered for Targeted Therapy.
    Morigi JJ, Stricker PD, van Leeuwen PJ, Tang R, Ho B, Nguyen Q, Hruby G, Fogarty G, Jagavkar R, Kneebone A, Hickey A, Fanti S, Tarlinton L, Emmett L.
    J Nucl Med; 2015 Aug 01; 56(8):1185-90. PubMed ID: 26112024
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Can initial prostate specific antigen determinations eliminate the need for bone scans in patients with newly diagnosed prostate carcinoma? A multicenter retrospective study in Japan.
    Kosuda S, Yoshimura I, Aizawa T, Koizumi K, Akakura K, Kuyama J, Ichihara K, Yonese J, Koizumi M, Nakashima J, Fujii H.
    Cancer; 2002 Feb 15; 94(4):964-72. PubMed ID: 11920464
    [Abstract] [Full Text] [Related]

  • 34. Efficacy of skeletal alkaline phosphatase and prostate-specific antigen in the diagnosis of bone metastasis in cancer of the prostate.
    Wolff JM, Ittel T, Borchers H, Brauers A, Jakse G.
    Urol Int; 1998 Oct 15; 61(1):12-6. PubMed ID: 9792976
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. The value of a baseline bone scan in patients with newly diagnosed prostate cancer.
    Lin K, Szabo Z, Chin BB, Civelek AC.
    Clin Nucl Med; 1999 Aug 15; 24(8):579-82. PubMed ID: 10439178
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.